Minnesota medical school weighing gift and grants ban

Share this article:
The University of Minnesota Medical School is weighing a tough ban on gifts to physicians and requiring docs to publicly disclose all relationships with drug companies, according to a university newspaper. 
Those measures are included in the recommendations of a University Medical School conflict-of-interest task force, which called for: limiting the use of samples and centralizing their distribution; curbing and ultimately eliminating industry funding for education; eliminating the $10,000 threshold defining a “significant financial interest” and requiring instead that all financial involvement be reported; registering clinical trials; a ban on ghostwriting and new disclosure requirements for publication of articles by university employees. 
In addition, under the task force plan, conflict-of-interest policies would be extended to non-human research, students and short-term faculty or those on leave. 
Instructors would be required to disclose relationships with drug companies to students, and doctors would be required to disclose industry ties directly to patients and online, through a university-administered site. 
In its executive summary, the task force acknowledged the value of some interactions with industry in research, care and education, but said “both real and perceived conflicts of interest between health professionals' financial interests and the best interests of patients can damage the image of the profession and the medical school.”
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

More in Features

Journal Ad Review: Reality Bites

Journal Ad Review: Reality Bites

Print's numbers may be taking some small steps in the right direction, but data is what the industry really wants to sink its teeth into. Larry Dobrow reports on what ...

Headliner: Proteus CEO takes an original path

Headliner: Proteus CEO takes an original path

Andrew Thompson, CEO, Proteus Digital Health

Leadership Exchange: How Do We Get Beyond the Pill?

Leadership Exchange: How Do We Get Beyond the ...

As its focus moves from manufacturing to service, pharma needs to partner with healthcare neophytes as well as established players. James Chase asks six experts to assess the risks and ...